[Treatment-refractory OCD and its biological pathophysiology]

Area of Science:

• Neuroscience
• Psychiatry
• Medical Imaging

Background:

• Selective serotonin reuptuptake inhibitors (SSRIs) and cognitive behavioral therapy are effective for OCD.
• Some patients remain refractory to standard treatments.
• Atypical antipsychotics and deep brain stimulation show promise for refractory OCD.

Purpose of the Study:

• To explore the neurobiological underpinnings of treatment-refractory obsessive-compulsive disorder (OCD).
• To investigate the role of neuro-circuit dysfunction, symptom subtypes, and comorbidities in treatment resistance.

Main Methods:

• Review of neuroimaging studies identifying metabolic and structural abnormalities in the frontal cortex, subcortical, and limbic structures.
• Analysis of associations between specific OCD symptom dimensions and neural correlates.
• Examination of the impact of comorbid conditions like depression and tic disorders on neuro-circuitry.

Main Results:

• Abnormally high metabolic activity in frontal, subcortical, and limbic regions may indicate treatment response.
• Structural and connective dysfunction in these areas is linked to treatment-refractory OCD.
• OCD heterogeneity, specific symptom dimensions, and comorbidities like depression and tic disorders complicate neuro-circuitry and contribute to treatment resistance.

Conclusions:

• Treatment-refractory OCD is associated with complex neuro-circuit dysfunction.
• Symptom heterogeneity and comorbidities significantly influence treatment outcomes.
• Further research is essential to develop biologically-informed treatment strategies for refractory OCD.